---

---

entities : Teva pharmaceutical industries ltd    symbols : JNJ   

save search

---

Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published: 2024-04-16 (Crawled : 21:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| 2.8% | O: -0.04% H: 0.28% C: -0.16%
stelara fda biosimilar approval teva

---

Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
ALVO | $13.39 0.45% 0.45% 200K |

n/a

| -12.48% | O: -1.58% H: 1.87% C: 0.53%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -4.15% | O: -0.03% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -5.79% | O: -0.89% H: 0.0% C: 0.0%
KMDA | $5.1 -0.99% 5.3K |

Health Technology

| -11.58% | O: 0.68% H: 0.0% C: -1.86%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| -0.42% | O: 0.58% H: 1.2% C: 0.84%
business year update financial results

---

Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
Published: 2024-03-11 (Crawled : 23:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 4.01% | O: 2.01% H: 0.0% C: -2.01%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -6.58% | O: 1.12% H: 0.0% C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M |

Health Technology

| -5.43% | O: 0.02% H: 0.79% C: 0.79%
LLY | News | $745.69 1.96% -0.16% 2M |

Health Technology

| -0.41% | O: 0.9% H: 2.03% C: 1.89%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -6.5% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -4.26% | O: 0.01% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 3.64% | O: -0.19% H: 0.22% C: -0.21%
global set growth market

---

Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging Population Fostering Growth
Published: 2024-02-28 (Crawled : 11:00) - prnewswire.com
ROIV | $10.935 3.16% 3.06% 5M |

Manufacturing

| -10.17% | O: -0.76% H: 0.51% C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -8.12% | O: 0.05% H: 0.06% C: -0.95%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -6.81% | O: 0.67% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -6.09% | O: 0.6% H: 0.02% C: -1.03%
global set dermatological advanced growth market

---

PARP Inhibitors Market to reach over USD 10.31 billion by the year 2031 - Exclusive Report by InsightAce Analytic
Published: 2024-02-21 (Crawled : 09:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 7.96% | O: -0.88% H: 1.75% C: -0.29%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -4.9% | O: 0.8% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -5.02% | O: -0.25% H: 0.0% C: 0.0%
KPTI | $1.085 -3.98% -4.15% 1.6M |

Health Technology

| -6.61% | O: -1.65% H: 3.36% C: 1.68%
CKPT | $1.43 -1.38% -1.4% 350K |

Health Technology

| -26.77% | O: 0.0% H: 1.26% C: -3.03%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 7.83% | O: -1.01% H: 1.1% C: 1.1%
report year reach market

---

Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published: 2024-02-15 (Crawled : 23:00) - prnewswire.com
TRUMF | $16.488 -17.59% 1.7K |

Health Technology

| -55.26% | O: 0.79% H: 0.0% C: -3.21%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 0.42% | O: 1.66% H: 0.0% C: -1.59%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -4.41% | O: 1.66% H: 0.0% C: -1.04%
TRUMY | $16.94 0.79% 52K |

Manufacturing

| -54.46% | O: 0.27% H: 0.0% C: -2.6%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -4.88% | O: 0.37% H: 0.57% C: 0.19%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -5.57% | O: -0.83% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -4.93% | O: 0.01% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -0.51% | O: -0.6% H: 0.0% C: 0.0%
drug patent report review global advanced market

---

Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)
Published: 2024-02-15 (Crawled : 12:00) - globenewswire.com
ALVO | $13.39 0.45% 0.45% 200K |

n/a

| -15.1% | O: 0.32% H: 2.98% C: 0.32%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -4.58% | O: -0.19% H: 1.6% C: 1.24%
KMDA | $5.1 -0.99% 5.3K |

Health Technology

| -13.64% | O: 1.66% H: 1.96% C: 0.49%
avt04 stelara biosimilar expected global market

---

Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published: 2024-02-14 (Crawled : 02:00) - prnewswire.com
LZAGF | $541.144 -19.1% 24 |

Health Technology

| 8.23% | O: 3.14% H: 1.92% C: 1.92%
GLAXF | News | $20.305 -14.18% 630 |

Health Technology

| -3.33% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -0.29% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 12.33% | O: 0.87% H: 0.21% C: -2.23%
LZAGY | $55.69 0.02% 29K |

Professional, Scientific, and T...

| 12.17% | O: 4.07% H: 1.53% C: 1.45%
TMO | News | $574.59 4.78% -1.12% 2.5M |

Health Technology

| 1.82% | O: 0.56% H: 1.3% C: 1.22%
TAK | News | $13.38 0.15% 0.9% 1.7M |

Health Technology

| -6.83% | O: 0.42% H: 1.04% C: 0.97%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -5.44% | O: -0.91% H: 0.0% C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M |

Health Technology

| -1.93% | O: 0.89% H: 0.41% C: 0.1%
LLY | News | $745.69 1.96% -0.16% 2M |

Health Technology

| -1.57% | O: 0.38% H: 2.44% C: 1.54%
BAX | $41.02 1.54% 0.0% 2.6M |

Health Technology

| 1.97% | O: 0.33% H: 0.63% C: -0.28%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -3.77% | O: -0.73% H: 0.0% C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M |

Health Technology

| -4.89% | O: -0.83% H: 0.66% C: 0.38%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| 0.23% | O: -1.1% H: 0.0% C: 0.0%
GLPG | News | $29.47 1.38% 1.36% 120K |

Health Technology

| -25.58% | O: -1.72% H: 1.8% C: 1.59%
BIIB | $193.18 -0.48% -0.48% 1.4M |

Health Technology

| -14.36% | O: 0.16% H: 0.43% C: -2.76%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 14.91% | O: 0.28% H: 0.93% C: 0.75%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| -6.39% | O: -0.21% H: 0.34% C: 0.07%
report global protein growth market

---

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630 |

Health Technology

| -1.11% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 14.97% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | News | $9.53 -1.11% 690K |

Manufacturing

| -11.92% | O: 0.37% H: 0.74% C: 0.28%
TAK | News | $13.38 0.15% 0.9% 1.7M |

Health Technology

| -6.64% | O: 0.14% H: 0.35% C: 0.07%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -5.73% | O: -0.34% H: 0.23% C: -1.13%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -4.78% | O: 0.7% H: 0.0% C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M |

Health Technology

| -1.17% | O: 1.22% H: 0.07% C: -0.43%
LLY | News | $745.69 1.96% -0.16% 2M |

Health Technology

| -0.8% | O: -0.96% H: 1.75% C: 1.75%
BMY | $48.99 -0.31% 0.0% 9.1M |

Health Technology

| -1.23% | O: -0.18% H: 0.48% C: -1.91%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -2.99% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | $15.13 0.93% 0.93% 470K |

Health Technology

| -17.68% | O: -1.15% H: 1.03% C: -1.5%
VRTX | $404.93 1.25% 1.43% 1.1M |

Health Technology

| -5.01% | O: -0.28% H: 0.49% C: -0.32%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| 0.16% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.425 -7.02% 2.7K |

Health Technology

| -6.2% | O: -3.1% H: 1.2% C: -0.8%
INCY | $51.62 -0.58% -0.58% 2.5M |

Health Technology

| -10.24% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $193.18 -0.48% -0.48% 1.4M |

Health Technology

| -20.69% | O: -3.72% H: 0.58% C: -3.82%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 14.2% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $375.13 1.73% 1.7% 340K |

Health Technology

| -6.1% | O: -2.3% H: 1.65% C: 0.83%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| -7.65% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

---

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200 |

Health Technology

| -12.32% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 3.65% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -7.55% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $64.93 -4.38% 6.2K |

Manufacturing

| 38.86% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | News | $9.53 -1.11% 690K |

Manufacturing

| -12.49% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.38 0.15% 0.9% 1.7M |

Health Technology

| -5.65% | O: 0.07% H: 0.42% C: 0.07%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -8.65% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -4.25% | O: 1.47% H: 0.0% C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M |

Health Technology

| 3.73% | O: 0.76% H: 4.31% C: 2.11%
BMY | $48.99 -0.31% 0.0% 9.1M |

Health Technology

| -0.24% | O: -0.14% H: 0.35% C: -1.12%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -1.83% | O: 1.48% H: 0.0% C: 0.0%
VRTX | $404.93 1.25% 1.43% 1.1M |

Health Technology

| -4.46% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -0.55% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $109.685 0.79% 0.78% 380K |

Health Technology

| -12.73% | O: -0.02% H: 0.0% C: -1.4%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 4.61% | O: -0.4% H: 0.19% C: -0.33%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| -13.97% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

---

Global Transdermal Skin Patches Market Forecast Report, 2024-2030: A $9.9B Projected Industry, Dominated by Teva Pharma, 3M Company, Nitto Denko Corporation, and Johnson & Johnson
Published: 2024-01-19 (Crawled : 18:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -11.28% | O: -0.19% H: 0.0% C: 0.0%
VTRS | News A | $11.36 0.98% 0.97% 4.7M |

Health Technology

| -0.18% | O: 0.0% H: 1.42% C: 1.15%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -12.27% | O: -0.44% H: 0.64% C: 0.63%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -6.76% | O: 0.67% H: 0.0% C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M |

Health Technology

| -6.24% | O: -0.24% H: 0.0% C: 0.0%
MMM | $93.0 0.41% -0.4% 3.7M |

Producer Manufacturing

| -12.98% | O: 0.28% H: 1.52% C: 0.96%
transdermal global teva skin market

---

Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200 |

Health Technology

| -21.02% | O: -2.79% H: 0.62% C: 0.62%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 2.34% | O: 2.06% H: 0.82% C: 0.82%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -1.82% | O: -1.29% H: 0.4% C: 0.4%
ALPMY | News | $9.53 -1.11% 690K |

Manufacturing

| -22.27% | O: -2.2% H: 0.0% C: -0.27%
TAK | News | $13.38 0.15% 0.9% 1.7M |

Health Technology

| -5.11% | O: -0.64% H: 0.5% C: 0.5%
NVO | News | $128.64 2.7% -0.07% 3.7M |

Health Technology

| 29.39% | O: -0.42% H: 0.67% C: 0.25%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -1.21% | O: 0.19% H: 0.35% C: 0.2%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -4.39% | O: -0.18% H: 0.0% C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M |

Health Technology

| 24.67% | O: 0.43% H: 0.0% C: 0.0%
BMY | $48.99 -0.31% 0.0% 9.1M |

Health Technology

| -2.03% | O: 0.2% H: 0.55% C: 0.1%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 13.6% | O: 0.3% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| 1.21% | O: 1.07% H: 0.0% C: 0.0%
GILD | $67.03 0.12% 0.12% 5.2M |

Health Technology

| -14.22% | O: 0.08% H: 1.45% C: 1.17%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| 0.22% | O: -0.05% H: 0.3% C: -0.76%
reach market

---

Pulmonary Arterial Hypertension Market Size Valuation Will Exceed USD 11.35 Billion By 2032, at 5.0% CAGR: Polaris Market Research
Published: 2023-11-29 (Crawled : 15:30) - prnewswire.com
VTRS | News A | $11.36 0.98% 0.97% 4.7M |

Health Technology

| 23.09% | O: 0.11% H: 0.44% C: -0.22%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -1.51% | O: -0.04% H: 0.0% C: 0.0%
UTHR | $234.445 0.16% 0.16% 420K |

Health Technology

| 1.59% | O: 0.35% H: 1.23% C: 0.38%
GILD | $67.03 0.12% 0.12% 5.2M |

Health Technology

| -10.15% | O: 0.46% H: 0.8% C: 0.51%
research hypertension market

---

Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®
Published: 2023-11-29 (Crawled : 09:00) - globenewswire.com
ALVO | $13.39 0.45% 0.45% 200K |

n/a

| 36.02% | O: 1.02% H: 0.0% C: -5.05%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -1.51% | O: -0.04% H: 0.0% C: 0.0%
KMDA | $5.1 -0.99% 5.3K |

Health Technology

| 8.46% | O: 0.73% H: 0.0% C: -1.04%
avt05 simponi biosimilar positive results study

---

Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $13.39 0.45% 0.45% 200K |

n/a

| 36.02% | O: 1.02% H: 0.0% C: -5.05%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -2.3% | O: 0.18% H: 0.12% C: -0.16%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -1.51% | O: -0.04% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 20.76% | O: -0.73% H: 0.78% C: 0.35%
KMDA | $5.1 -0.99% 5.3K |

Health Technology

| 8.46% | O: 0.73% H: 0.0% C: -1.04%
business update financial results

---

Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $13.39 0.45% 0.45% 200K |

n/a

| 36.02% | O: 1.02% H: 0.0% C: -5.05%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -1.51% | O: -0.04% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 20.76% | O: -0.73% H: 0.78% C: 0.35%
KMDA | $5.1 -0.99% 5.3K |

Health Technology

| 8.46% | O: 0.73% H: 0.0% C: -1.04%
business update financial results

---

HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published: 2023-11-17 (Crawled : 16:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -0.26% | O: 0.78% H: 0.0% C: 0.0%
BMY | $48.99 -0.31% 0.0% 9.1M |

Health Technology

| -3.34% | O: 0.69% H: 0.06% C: -0.68%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 21.41% | O: 0.01% H: 0.0% C: 0.0%
GILD | $67.03 0.12% 0.12% 5.2M |

Health Technology

| -10.16% | O: 0.5% H: 0.82% C: 0.75%
reach research hiv market

---

Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki (AVT04), the First Biosimilar of Stelara® (ustekinumab)
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
ALVO | $13.39 0.45% 0.45% 200K |

n/a

| 47.78% | O: 0.33% H: 3.87% C: -0.55%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| 1.15% | O: 0.17% H: 0.0% C: 0.0%
KMDA | $5.1 -0.99% 5.3K |

Health Technology

| 8.35% | O: 0.21% H: 1.67% C: 1.25%
avt04 stelara pharma biosimilar authorization

---

Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program
Published: 2023-11-13 (Crawled : 13:30) - biospace.com/
TEVA | $13.01 1.01% 0.0% 8.9M |

Health Technology

| 48.39% | O: -0.92% H: 4.53% C: 2.56%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| 0.65% | O: -0.5% H: 0.0% C: 0.0%
RPRX | $27.82 0.0% 3.5M |

Health Technology

| 2.2% | O: -0.44% H: 0.59% C: 0.04%
pharma royalty teva program

---

Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
Published: 2023-11-13 (Crawled : 13:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| 0.65% | O: -0.5% H: 0.0% C: 0.0%
RPRX | $27.82 0.0% 3.5M |

Health Technology

| 2.2% | O: -0.44% H: 0.59% C: 0.04%
pharma royalty teva program

---

Gainers vs Losers

78%

22%

Top 10 Gainers

MTTR | News 4 | $4.6 164.37% 62.17% 28M |

AGBA | $2.94 135.2% 57.48% 66M |

Finance

EDBL | News | $6.46 71.81% 41.8% 2M |

MTC | $2.25 44.23% 30.67% 6M |

Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M |

Finance

SHIM | $3.05 35.56% 26.23% 1.1M |

HKIT | $1.345 31.86% 24.16% 390K |

Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M |

Wholesale Trade

OST | $0.512 28.0% 21.88% 290K |

POET | $1.59 27.2% 21.38% 4.2M |

Manufacturing

---

Your saved searches

---